Andra Krauze

1.5k total citations
64 papers, 1.0k citations indexed

About

Andra Krauze is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andra Krauze has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 26 papers in Pulmonary and Respiratory Medicine and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andra Krauze's work include Glioma Diagnosis and Treatment (33 papers), Radiomics and Machine Learning in Medical Imaging (17 papers) and Brain Metastases and Treatment (12 papers). Andra Krauze is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Radiomics and Machine Learning in Medical Imaging (17 papers) and Brain Metastases and Treatment (12 papers). Andra Krauze collaborates with scholars based in United States, Canada and United Kingdom. Andra Krauze's co-authors include Kevin Camphausen, Ying Zhuge, Holly Ning, Erdal Taşçı, Jason Cheng, Joanna H. Shih, Robert W. Miller, John O’Connell, Cody D. Schlaff and Arnaud Belard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Andra Krauze

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andra Krauze United States	15	373	351	347	229	164	64	1.0k
Corey Neff United States	11	993 2.7×	269 0.8×	368 1.1×	463 2.0×	141 0.9×	22	1.8k
Shyam Tanguturi United States	14	440 1.2×	238 0.7×	289 0.8×	214 0.9×	45 0.3×	42	914
Lisa Scarpace United States	23	1.2k 3.3×	1.4k 4.0×	321 0.9×	184 0.8×	76 0.5×	40	2.0k
Archya Dasgupta India	15	259 0.7×	306 0.9×	160 0.5×	90 0.4×	37 0.2×	75	615
Leland Hu United States	17	1.2k 3.2×	974 2.8×	234 0.7×	276 1.2×	134 0.8×	61	1.9k
MacLean P. Nasrallah United States	23	761 2.0×	543 1.5×	223 0.6×	319 1.4×	96 0.6×	97	1.5k
Pallavi Tiwari United States	20	537 1.4×	1.8k 5.1×	661 1.9×	96 0.4×	122 0.7×	71	2.2k
Sebastian Echegaray United States	16	257 0.7×	1.3k 3.7×	542 1.6×	80 0.3×	38 0.2×	22	1.5k
Qiang Tian China	20	483 1.3×	973 2.8×	212 0.6×	83 0.4×	125 0.8×	47	1.4k
Albert J. S. Idema Netherlands	12	570 1.5×	342 1.0×	158 0.5×	273 1.2×	108 0.7×	15	1.2k

Countries citing papers authored by Andra Krauze

Since Specialization

Citations

This map shows the geographic impact of Andra Krauze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andra Krauze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andra Krauze more than expected).

Fields of papers citing papers by Andra Krauze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andra Krauze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andra Krauze. The network helps show where Andra Krauze may publish in the future.

Co-authorship network of co-authors of Andra Krauze

This figure shows the co-authorship network connecting the top 25 collaborators of Andra Krauze. A scholar is included among the top collaborators of Andra Krauze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andra Krauze. Andra Krauze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camphausen, Kevin, et al.. (2024). Small Bowel Dose Constraints in Radiation Therapy—Where Omics-Driven Biomarkers and Bioinformatics Can Take Us in the Future. SHILAP Revista de lepidopterología. 4(1). 158–172. 1 indexed citations

Belue, Mason J., Stephanie A. Harmon, Ying Zhuge, et al.. (2024). Diagnosing Progression in Glioblastoma—Tackling a Neuro-Oncology Problem Using Artificial-Intelligence-Derived Volumetric Change over Time on Magnetic Resonance Imaging to Examine Progression-Free Survival in Glioblastoma. Diagnostics. 14(13). 1374–1374. 8 indexed citations

Taşçı, Erdal, Yajas Shah, Ying Zhuge, et al.. (2024). MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma. International Journal of Molecular Sciences. 25(7). 4082–4082. 6 indexed citations

Taşçı, Erdal, Ying Zhuge, Longze Zhang, et al.. (2024). MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in Glioblastoma. International Journal of Molecular Sciences. 25(20). 10965–10965. 4 indexed citations

Sproull, Mary, et al.. (2024). Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management. International Journal of Radiation Oncology*Biology*Physics. 120(2). e271–e271. 1 indexed citations

Erickson, Andrew, L. R. Jackson, Kevin Camphausen, & Andra Krauze. (2024). Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction. Biomedicines. 12(12). 2806–2806. 1 indexed citations

Taşçı, Erdal, et al.. (2023). An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma. Current Oncology. 30(9). 8278–8293. 15 indexed citations

Krauze, Andra, et al.. (2023). CLRM-04 DEVELOPING A WORD LEXICON FOR VENOUS THROMBOEMBOLISM DATA ANNOTATION USING RADIOLOGY REPORTS IN GLIOBLASTOMA PATIENTS - LINKING LARGE-SCALE DATA SETS TO EXPAND CLINICAL FEATURES FOR AI. Neuro-Oncology Advances. 5(Supplement_3). iii7–iii8.

Krauze, Andra, Michael Sierk, Qingrong Chen, et al.. (2023). Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel. Frontiers in Oncology. 13. 1127645–1127645. 7 indexed citations

10.

Taşçı, Erdal, et al.. (2023). GradWise: A Novel Application of a Rank-Based Weighted Hybrid Filter and Embedded Feature Selection Method for Glioma Grading with Clinical and Molecular Characteristics. Cancers. 15(18). 4628–4628. 9 indexed citations

11.

Taşçı, Erdal, Ying Zhuge, Mary Sproull, et al.. (2023). RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma. Cancers. 15(10). 2672–2672. 10 indexed citations

12.

Krauze, Andra, Yingdong Zhao, Ming‐Chung Li, et al.. (2023). Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation. Biomolecules. 13(10). 1499–1499. 7 indexed citations

13.

Zhuge, Ying, Holly Ning, Jason Cheng, et al.. (2023). Survival Prediction in Glioblastoma Using Combination of Deep Learning and Hand-Crafted Radiomic Features in MRI Images. Journal of Advances in Information Technology. 14(6). 1461–1469. 1 indexed citations

14.

Taşçı, Erdal, et al.. (2022). 3D Multimodal Brain Tumor Segmentation and Grading Scheme based on Machine, Deep, and Transfer Learning Approaches. 5 indexed citations

15.

Fan, Kevin Yijun, Nafisha Lalani, Nathalie LeVasseur, et al.. (2020). Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy. Journal of Neuro-Oncology. 151(2). 231–240. 5 indexed citations

16.

Rousseau, Étienne, et al.. (2019). Patterns of Prostate Cancer Recurrence after Brachytherapy Imaged with PSMA-Targeting 18F-Dcfpyl PET/CT. International Journal of Radiation Oncology*Biology*Physics. 105(1). E304–E305. 1 indexed citations

17.

Rousseau, Étienne, Don Wilson, Andra Krauze, et al.. (2019). A Prospective Study on ¹⁸F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer. Journal of Nuclear Medicine. 60(11). 1587–1593. 81 indexed citations

18.

Valle, Luca, Matthew D. Greer, Joanna H. Shih, et al.. (2018). Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy. Diagnostic and Interventional Radiology. 24(1). 46–53. 21 indexed citations

19.

Schlaff, Cody D., Andra Krauze, Arnaud Belard, John O’Connell, & Kevin Camphausen. (2014). Bringing the heavy: carbon ion therapy in the radiobiological and clinical context. Radiation Oncology. 9(1). 88–88. 115 indexed citations

20.

Krauze, Andra, Minhee Won, B. Corn, et al.. (2013). Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). Biomarker Research. 1(1). 29–29. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact